Mark Massaro
Stock Analyst at BTIG
(4.44)
# 260
Out of 4,853 analysts
137
Total ratings
52.94%
Success rate
18.22%
Average return
Main Sectors:
Stocks Rated by Mark Massaro
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| TEM Tempus AI | Initiates: Buy | $60 | $58.66 | +2.28% | 1 | Apr 21, 2025 | |
| ADPT Adaptive Biotechnologies | Maintains: Buy | $8 → $9 | $9.87 | -8.81% | 5 | Dec 18, 2024 | |
| EXAS Exact Sciences | Maintains: Buy | $65 → $75 | $54.38 | +37.92% | 16 | Nov 26, 2024 | |
| BNGO Bionano Genomics | Downgrades: Neutral | n/a | $3.68 | - | 8 | Sep 10, 2024 | |
| DNA Ginkgo Bioworks Holdings | Maintains: Sell | $0.2 → $7 | $7.23 | -3.18% | 6 | Aug 23, 2024 | |
| PSNL Personalis | Maintains: Buy | $5.5 → $7 | $5.06 | +38.34% | 1 | Aug 16, 2024 | |
| ZTS Zoetis | Maintains: Buy | $220 → $225 | $168.61 | +33.44% | 2 | Aug 12, 2024 | |
| NTRA Natera | Maintains: Buy | $125 → $135 | $165.51 | -18.43% | 13 | Aug 9, 2024 | |
| AKYA Akoya Biosciences | Downgrades: Neutral | n/a | $1.13 | - | 3 | Aug 6, 2024 | |
| WGS GeneDx Holdings | Maintains: Buy | $35 → $45 | $69.17 | -34.94% | 4 | Jul 31, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $45 → $50 | $48.41 | +3.28% | 2 | Jul 30, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $580 | $522.21 | +11.07% | 1 | Jul 25, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $23 → $21 | $7.13 | +194.53% | 4 | May 2, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $10 → $8 | $2.15 | +272.09% | 3 | Mar 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $5.78 | - | 1 | Mar 12, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $7 → $8 | $2.08 | +285.54% | 8 | Mar 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $7 → $8 | $3.08 | +159.74% | 2 | Mar 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $38 → $30 | $17.02 | +76.32% | 4 | Jun 15, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $6 → $5 | $7.19 | -30.46% | 3 | Mar 22, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $28 → $25 | $18.77 | +33.23% | 2 | Feb 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $1.38 | - | 1 | Jan 20, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $5 → $3.5 | $1.21 | +189.26% | 2 | Nov 18, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $100 | $2.97 | +3,267.00% | 1 | Nov 30, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $350 → $300 | $82.25 | +264.74% | 6 | Sep 22, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $52 → $50 | $63.07 | -20.72% | 9 | Nov 11, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $108 → $112 | $173.65 | -35.50% | 10 | Jul 24, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $155 → $165 | $252.15 | -34.56% | 10 | May 2, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $78 → $80 | $29.90 | +167.56% | 9 | Sep 10, 2018 |
Tempus AI
Apr 21, 2025
Initiates: Buy
Price Target: $60
Current: $58.66
Upside: +2.28%
Adaptive Biotechnologies
Dec 18, 2024
Maintains: Buy
Price Target: $8 → $9
Current: $9.87
Upside: -8.81%
Exact Sciences
Nov 26, 2024
Maintains: Buy
Price Target: $65 → $75
Current: $54.38
Upside: +37.92%
Bionano Genomics
Sep 10, 2024
Downgrades: Neutral
Price Target: n/a
Current: $3.68
Upside: -
Ginkgo Bioworks Holdings
Aug 23, 2024
Maintains: Sell
Price Target: $0.2 → $7
Current: $7.23
Upside: -3.18%
Personalis
Aug 16, 2024
Maintains: Buy
Price Target: $5.5 → $7
Current: $5.06
Upside: +38.34%
Zoetis
Aug 12, 2024
Maintains: Buy
Price Target: $220 → $225
Current: $168.61
Upside: +33.44%
Natera
Aug 9, 2024
Maintains: Buy
Price Target: $125 → $135
Current: $165.51
Upside: -18.43%
Akoya Biosciences
Aug 6, 2024
Downgrades: Neutral
Price Target: n/a
Current: $1.13
Upside: -
GeneDx Holdings
Jul 31, 2024
Maintains: Buy
Price Target: $35 → $45
Current: $69.17
Upside: -34.94%
Jul 30, 2024
Maintains: Buy
Price Target: $45 → $50
Current: $48.41
Upside: +3.28%
Jul 25, 2024
Initiates: Buy
Price Target: $580
Current: $522.21
Upside: +11.07%
May 2, 2024
Maintains: Buy
Price Target: $23 → $21
Current: $7.13
Upside: +194.53%
Mar 13, 2024
Maintains: Buy
Price Target: $10 → $8
Current: $2.15
Upside: +272.09%
Mar 12, 2024
Downgrades: Neutral
Price Target: n/a
Current: $5.78
Upside: -
Mar 7, 2024
Maintains: Buy
Price Target: $7 → $8
Current: $2.08
Upside: +285.54%
Mar 6, 2024
Maintains: Buy
Price Target: $7 → $8
Current: $3.08
Upside: +159.74%
Jun 15, 2023
Maintains: Buy
Price Target: $38 → $30
Current: $17.02
Upside: +76.32%
Mar 22, 2023
Maintains: Buy
Price Target: $6 → $5
Current: $7.19
Upside: -30.46%
Feb 28, 2023
Maintains: Buy
Price Target: $28 → $25
Current: $18.77
Upside: +33.23%
Jan 20, 2023
Downgrades: Neutral
Price Target: n/a
Current: $1.38
Upside: -
Nov 18, 2022
Maintains: Buy
Price Target: $5 → $3.5
Current: $1.21
Upside: +189.26%
Nov 30, 2020
Initiates: Buy
Price Target: $100
Current: $2.97
Upside: +3,267.00%
Sep 22, 2020
Maintains: Hold
Price Target: $350 → $300
Current: $82.25
Upside: +264.74%
Nov 11, 2019
Maintains: Hold
Price Target: $52 → $50
Current: $63.07
Upside: -20.72%
Jul 24, 2019
Maintains: Buy
Price Target: $108 → $112
Current: $173.65
Upside: -35.50%
May 2, 2019
Maintains: Hold
Price Target: $155 → $165
Current: $252.15
Upside: -34.56%
Sep 10, 2018
Maintains: Buy
Price Target: $78 → $80
Current: $29.90
Upside: +167.56%